Literature DB >> 16543155

A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.

Peter S Brzovic1, Alexei Lissounov, Devin E Christensen, David W Hoyt, Rachel E Klevit.   

Abstract

Protein ubiquitination is a powerful regulatory modification that influences nearly every aspect of eukaryotic cell biology. The general pathway for ubiquitin (Ub) modification requires the sequential activities of a Ub-activating enzyme (E1), a Ub transfer enzyme (E2), and a Ub ligase (E3). The E2 must recognize both the E1 and a cognate E3 in addition to carrying activated Ub. These central functions are performed by a topologically conserved alpha/beta-fold core domain of approximately 150 residues shared by all E2s. However, as presented herein, the UbcH5 family of E2s can also bind Ub noncovalently on a surface well removed from the E2 active site. We present the solution structure of the UbcH5c/Ub noncovalent complex and demonstrate that this noncovalent interaction permits self-assembly of activated UbcH5c approximately Ub molecules. Self-assembly has profound consequences for the processive formation of polyubiquitin (poly-Ub) chains in ubiquitination reactions directed by the breast and ovarian cancer tumor susceptibility protein BRCA1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16543155     DOI: 10.1016/j.molcel.2006.02.008

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  151 in total

1.  E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP.

Authors:  Sarah E Soss; Yuanyuan Yue; Sirano Dhe-Paganon; Walter J Chazin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Insights into ubiquitin-conjugating enzyme/ co-activator interactions from the structure of the Pex4p:Pex22p complex.

Authors:  Chris Williams; Marlene van den Berg; Santosh Panjikar; Will A Stanley; Ben Distel; Matthias Wilmanns
Journal:  EMBO J       Date:  2011-11-15       Impact factor: 11.598

Review 3.  Twists and turns in ubiquitin-like protein conjugation cascades.

Authors:  Brenda A Schulman
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

4.  Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover.

Authors:  Nikita Popov; Christina Schülein; Laura A Jaenicke; Martin Eilers
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

Review 5.  Post-translational modifications in signal integration.

Authors:  Yonathan Lissanu Deribe; Tony Pawson; Ivan Dikic
Journal:  Nat Struct Mol Biol       Date:  2010-05-23       Impact factor: 15.369

6.  Mechanism of polyubiquitin chain recognition by the human ubiquitin conjugating enzyme Ube2g2.

Authors:  William E Bocik; Aroop Sircar; Jeffrey J Gray; Joel R Tolman
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

Review 7.  Structural and functional insights to ubiquitin-like protein conjugation.

Authors:  Frederick C Streich; Christopher D Lima
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

8.  Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a non-covalent ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway.

Authors:  David M Duda; Robert C A M van Waardenburg; Laura A Borg; Sierra McGarity; Amanda Nourse; M Brett Waddell; Mary-Ann Bjornsti; Brenda A Schulman
Journal:  J Mol Biol       Date:  2007-04-10       Impact factor: 5.469

9.  Structural and functional characterization of the monomeric U-box domain from E4B.

Authors:  Kyle A Nordquist; Yoana N Dimitrova; Peter S Brzovic; Whitney B Ridenour; Kim A Munro; Sarah E Soss; Richard M Caprioli; Rachel E Klevit; Walter J Chazin
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

Review 10.  Ubiquitin-binding domains - from structures to functions.

Authors:  Ivan Dikic; Soichi Wakatsuki; Kylie J Walters
Journal:  Nat Rev Mol Cell Biol       Date:  2009-10       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.